Development of Tetravalent, Bispecific CCR5 Antibodies With Antiviral Activity Against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00215-10